Phase I Clinical Trial Assessing the Mek Inhibitor Selumetinib (azd6244; Arry-142886) with Concomitant Thoracic Radiotherapy (rt) in Patients with Stage Iii-iv Non Small Cell Lung Cancer (nsclc)

A Fusi, F Blackhall, P Koh, C Dive, I Stratford, K Williams, N Bayman, L Ashcroft, T Coyne, S Falk, C Faivre-Finn

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Pages (from-to)S553-S554
Number of pages2
JournalJournal of Thoracic Oncology
Publication statusPublished - Nov 2013


  • MEK inhibitor
  • Non small cell lung cancer
  • Phase I trial
  • Thoracic radiotherapy

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this